乐观
$146.16
情景价格
$247.740
+8.299 (+3.35%)收盘时
Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and others. It also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as owns a urology management services organization (MSO). Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. It connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
Cardinal Health Inc is a good buy right now due to its strong recent performance and positive growth outlook. The current price is $237.57, and analysts have set price targets as high as $280, indicating potential upside of over 17%. Additionally, the company has shown a year-to-date change of +15.48% and a one-year change of +53.96%, reflecting robust growth. However, the main risk is its current ratio of 0.88, indicating potential liquidity concerns.
RBC Capital
$276
2026-08-19
RBC Capital
2026-08-19
目标价
$276
TD Cowen
$280
2026-08-13
TD Cowen
2026-08-13
目标价
$280
JPMorgan
$260
2026-08-13
JPMorgan
2026-08-13
目标价
$260
Barclays
$275
2026-08-13
Barclays
2026-08-13
目标价
$275
Morgan Stanley
$265
2026-08-12
Morgan Stanley
2026-08-12
目标价
$265
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

US Stocks Decline Due to Inflation Data

Wall Street Rally on Friday, Tech Stocks Rebound

Market Dynamics and Investment Strategies Analysis

Market Update: S&P 500 Stabilizes Amid Bond Yield Fluctuations

Stocks Decline as Treasury Yields Surge to 20-Year Highs
Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and others. It also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as owns a urology management services organization (MSO). Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. It connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination. It operates in the Healthcare sector (WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRI industry).
Cardinal Health Inc is a good buy right now due to its strong recent performance and positive growth outlook. The current price is $237.57, and analysts have set price targets as high as $280, indicating potential upside of over 17%. Additionally, the company has shown a year-to-date change of +15.48% and a one-year change of +53.96%, reflecting robust growth. However, the main risk is its current ratio of 0.88, indicating potential liquidity concerns.
16 analysts cover CAH: 1 rate it Buy, 15 Hold and 0 Sell. The average price target is 225.18.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。